| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -6.69K | 100% | $0.58 | -$3.88K |
| Net | -1 | -6.69K | -100% | -$3.88K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Morningside Venture Investments Ltd | 10%+ Owner | $1.75M | Aug 15, 2023 | ||
| Mark C. Schiller | Chief Legal Officer | $19.1K | -$3.88K | -16.8% | Mar 27, 2025 |
| Elizabeth Garner | Director | Jun 20, 2024 | |||
| Micki Klearman | Director | Jun 20, 2024 | |||
| Jason Dinges | Director | Jun 28, 2021 | |||
| Nicholas Michael Mordwinkin | Chief Business Officer | Jan 7, 2024 | |||
| Christopher J. Kirk | CEO, Director | Jan 9, 2025 | |||
| Courtney Wallace | Director | Jun 20, 2024 | |||
| John Franklin Fowler | Director | Feb 14, 2025 | |||
| Jean-Pierre Sommadossi | Director | Jun 28, 2021 | |||
| Michael Kauffman | Director | Jun 20, 2024 | |||
| Marc Belsky | Chief Financial Officer | Mar 27, 2025 | |||
| Noreen Henig | Chief Medical Officer | Jul 24, 2023 | |||
| Franklin M. Berger | Director | Jun 20, 2024 | |||
| Zung Phoung To | SVP, Clinical Development | Apr 1, 2025 | |||
| Graham K. Cooper | Director | Jun 20, 2024 | |||
| Pichi Luo Chiang | SVP, Corporate Controller | Apr 1, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|